share_log

Oppenheimer Maintains Outperform on Prothena Corp, Raises Price Target to $110

Benzinga Real-time News ·  Sep 29, 2022 10:13

Oppenheimer analyst Jay Olson maintains Prothena Corp (NASDAQ:PRTA) with a Outperform and raises the price target from $100 to $110.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment